Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GRPN | UPWK |
|---|---|---|
| Price | $18.43 | $8.40 |
| Change today | ▼ 2.18% | ▲ 0.48% |
| Market cap | $749.46M | $1.05B |
| Return, 3 months | -30.7% | -3.2% |
| Return, year to date | +4.7% | -57.6% |
| Return, 1 year | -16.7% | -53.0% |
| P/E (TTM) | -5.9 | 10.8 |
| P/B | -10.4 | 1.7 |
| P/E percentile vs own 5y | 41st | 66th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -0.8% | -1.7% |
| Net profit growth (YoY) | -107.1% | -22.4% |
| Gross margin | 90.7% | 77.2% |
| Operating margin | 1.5% | 15.1% |
| Net margin | -25.3% | 12.9% |
| Return on equity | – | 16.7% |
| Analyst target vs. price | +55.6% | +19.0% |
| Analyst buy share | 67% | 40% |
| RSI (14) | 41 | 49 |
| 30-day volatility | 62.5% | 34.4% |
| Max drawdown, 1 year | -58.7% | -64.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
